Latest news
Global pharma giants turn to Chinese biotech to tap innovation, valuation growth - South China Morning PostSouth China Morning Post · Sat, 08 Aug 2026 10:34:51 GMT$400B AstraZeneca-Bristol Myers Squibb merger rumor draws market reaction - AxiosAxios · Fri, 07 Aug 2026 21:39:29 GMTThe Merger Paradox: Why Transformational Mergers Create Extraordinary Value and Frequently Fail - Pharmaceutical ExecutivePharmaceutical Executive · Fri, 07 Aug 2026 10:07:38 GMTThe Week in Health: Pharma Mega-Merger Talks, Hospital Push - Mexico Business NewsMexico Business News · Thu, 06 Aug 2026 22:33:33 GMTManufacturing Strategies: AstraZeneca - DCAT Value Chain InsightsDCAT Value Chain Insights · Thu, 06 Aug 2026 21:00:00 GMTBig Pharma Can't Merge Its Way Out Of An Innovation Problem - Life Science LeaderLife Science Leader · Thu, 06 Aug 2026 18:18:04 GMTRecon: FDA approves first drug for type 1 narcolepsy, mRNA flu vaccine; No merger talks between AstraZeneca-BMS - RAPSRAPS · Thu, 06 Aug 2026 18:15:00 GMTCSPC Pharmaceutical, AstraZeneca Form Joint Venture for New Biologics Manufacturing Facility in China - BioPharm InternationalBioPharm International · Thu, 06 Aug 2026 16:59:36 GMT